Skip to content

Simvastatin Versus MTA in Pulpotomy of Immature Permanent Molars

Clinical and Digital Radiographic Evaluation of Simvastatin Versus MTA in Pulpotomy of Immature Permanent Vital Molars: A18 Month Randomized Controlled Trial

Status
UNKNOWN
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05878158
Enrollment
128
Registered
2023-05-26
Start date
2023-04-01
Completion date
2024-09-01
Last updated
2023-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulp Exposure, Dental

Brief summary

the study will be done to evaluate the clinical and digital radiographic success of simvastatin versus MTA in pulpotomy of immature permanent molars

Detailed description

the clinical and digital radiographic success of simvastatin versus MTA in pulpotomy of immature permanent molars for the following patients which include: Healthy children aged from 6 to 8 years who will be classified as Class I or II Children according to the American Society of Anaesthesiologists (ASA) will be included. Children with severe behavioral, or emotional disabilities, and medically compromised children will be excluded.

Interventions

DRUGSimvastatin

pulpotomy of immature permanent teeth

Sponsors

Ahmad Elheeny
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
6 Years to 8 Years
Healthy volunteers
No

Inclusion criteria

* Healthy children aged from 6 to 8 years * Children with severe behavioral, or emotional disabilities, and medically compromised children will be excluded. * Deep carious lesions of the first permanent immature molars with signs & symptoms of reversible pulpitis will be included * Normal radiographic findings and immature roots

Design outcomes

Primary

MeasureTime frameDescription
Presence or absence of painone yearclinical assessment

Secondary

MeasureTime frameDescription
Dentin wall thickness18 monthsradiographic assessment

Countries

Egypt

Contacts

Primary Contactmohamed aboalftooh, doctora
Doctormasmanlover22@gmail.com01092183998

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026